The startup has developed a medical imaging platform that utilizes heat diffusion signals to create real-time images for early cancer detection at the point of care and in operating rooms. This non-invasive technology enables clinicians to accurately identify and classify cancer in subcutaneous and dermal masses, facilitating timely diagnosis and treatment.
Funding
$15.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current cancer detection methods often rely on invasive procedures, expensive analyses, and may not provide immediate results, leading to delays in diagnosis and treatment. This is true for both human and veterinary medicine. A significant percentage of masses detected in animals are not even diagnosed due to these limitations.
Solution
HT BioImaging offers Heat Diffusion Imaging (HDI) technology, a non-invasive medical imaging platform that detects and classifies cancer early. The platform measures heat diffusion in biological tissues, translating the heat diffusion signal into an image using signal analysis, computer vision, and AI algorithms. This allows for the differentiation between cancerous and non-cancerous tissues at a very early stage, at the point of care and in operating rooms. For veterinary applications, HT Vista is a screening tool that enables veterinarians to rule out cancer in subcutaneous and dermal masses within minutes.
Target Audience
The primary target audience includes oncologists and radiologists in human medicine, as well as veterinarians and nurses in veterinary medicine, seeking tools for early and accurate cancer detection.
Features
- Heat Diffusion Imaging (HDI) technology based on measuring heat diffusion in biological tissues
- Proprietary algorithms using signal analysis, computer vision, and AI to analyze heat diffusion responses
- Ability to distinguish between cancer and other pathologies (pre-cancer, benign growths, necrosis)
- Non-invasive and real-time procedure
- HT Vista: a non-invasive screening tool for veterinary use, classifying and detecting cancer in animals earlier
- HTOScan has been tested on 150 patients in a clinical trial (USA & Israel) showing above 90% accuracy in detecting cancer